BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25636762)

  • 1. Nanoparticle-based brachytherapy spacers for delivery of localized combined chemoradiation therapy.
    Kumar R; Belz J; Markovic S; Jadhav T; Fowle W; Niedre M; Cormack R; Makrigiorgos MG; Sridhar S
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):393-400. PubMed ID: 25636762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling gold nanoparticle-eluting spacer degradation during brachytherapy application with in situ dose painting.
    Boateng F; Ngwa W
    Br J Radiol; 2017 Jun; 90(1074):20170069. PubMed ID: 28383280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor.
    Mukerji R; Schaal J; Li X; Bhattacharyya J; Asai D; Zalutsky MR; Chilkoti A; Liu W
    Biomaterials; 2016 Feb; 79():79-87. PubMed ID: 26702586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared fluorescence imaging platform for quantifying in vivo nanoparticle diffusion from drug loaded implants.
    Markovic S; Belz J; Kumar R; Cormack RA; Sridhar S; Niedre M
    Int J Nanomedicine; 2016; 11():1213-23. PubMed ID: 27069363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy.
    Saw PE; Yu M; Choi M; Lee E; Jon S; Farokhzad OC
    Biomaterials; 2017 Apr; 123():118-126. PubMed ID: 28167390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous liquid interface production of 3D printed drug-loaded spacers to improve prostate cancer brachytherapy treatment.
    Hagan CT; Bloomquist C; Kim I; Knape NM; Byrne JD; Tu L; Wagner K; Mecham S; DeSimone J; Wang AZ
    Acta Biomater; 2022 Aug; 148():163-170. PubMed ID: 35724920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices.
    Cormack RA; Sridhar S; Suh WW; D'Amico AV; Makrigiorgos GM
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):615-23. PubMed ID: 19879699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachytherapy application with in situ dose painting administered by gold nanoparticle eluters.
    Sinha N; Cifter G; Sajo E; Kumar R; Sridhar S; Nguyen PL; Cormack RA; Makrigiorgos GM; Ngwa W
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):385-92. PubMed ID: 25482302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles.
    Song B; Wu C; Chang J
    Acta Biomater; 2012 May; 8(5):1901-7. PubMed ID: 22326789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
    Knežević NŽ; Lin VS
    Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exovascular application of epigallocatechin-3-O-gallate-releasing electrospun poly(L-lactide glycolic acid) fiber sheets to reduce intimal hyperplasia in injured abdominal aorta.
    Lee MH; Kwon BJ; Koo MA; Jang EH; Seon GM; Park JC
    Biomed Mater; 2015 Sep; 10(5):055010. PubMed ID: 26391656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules.
    Sánchez-Moreno P; Buzón P; Boulaiz H; Peula-García JM; Ortega-Vinuesa JL; Luque I; Salvati A; Marchal JA
    Biomaterials; 2015 Aug; 61():266-78. PubMed ID: 26005765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIR photoregulated chemo- and photodynamic cancer therapy based on conjugated polyelectrolyte-drug conjugate encapsulated upconversion nanoparticles.
    Yuan Y; Min Y; Hu Q; Xing B; Liu B
    Nanoscale; 2014 Oct; 6(19):11259-72. PubMed ID: 25130329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
    Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
    J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect-related luminescent mesoporous silica nanoparticles employed for novel detectable nanocarrier.
    Ge K; Zhang C; Jia G; Ren H; Wang J; Tan A; Liang XJ; Zang A; Zhang J
    ACS Appl Mater Interfaces; 2015 May; 7(20):10905-14. PubMed ID: 25943277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendrimerlike mesoporous silica nanoparticles as pH-responsive nanocontainers for targeted drug delivery and bioimaging.
    Dai L; Zhang Q; Li J; Shen X; Mu C; Cai K
    ACS Appl Mater Interfaces; 2015 Apr; 7(13):7357-72. PubMed ID: 25765172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA-Mesoporous Silicon Microspheres for the in Vivo Controlled Temporospatial Delivery of Proteins.
    Minardi S; Pandolfi L; Taraballi F; De Rosa E; Yazdi IK; Liu X; Ferrari M; Tasciotti E
    ACS Appl Mater Interfaces; 2015 Aug; 7(30):16364-73. PubMed ID: 26108253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hyaluronic acid nanogel for photo-chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin.
    Khatun Z; Nurunnabi M; Nafiujjaman M; Reeck GR; Khan HA; Cho KJ; Lee YK
    Nanoscale; 2015 Jun; 7(24):10680-9. PubMed ID: 26030737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.